GlassScriptPhysician profile
Richard Elsworth
NPI 1407954589
$17,046.47
in general payments reported to CMS, 2019-2025
30 companies · $3,107 in 2025
The $3,107 reported for 2025 was more than what 96% of Obstetrics providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,960 · 2020: $652 · 2021: $4,600 · 2022: $3,018 · 2023: $3,188 · 2024: $522 · 2025: $3,107.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $5,587 · Food and Beverage: $1,229.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $5,587.10 |
| Food and Beverage | $1,229.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $11,095.26 | 2021-2025 | Nexplanon |
| Merck Sharp & Dohme LLC | $2,844.20 | 2019-2021 | |
| Coloplast Corp | $1,490.51 | 2019-2025 | Restorelle |
| Abbvie INC. | $370.38 | 2019-2024 | |
| Therapeuticsmd, INC. | $113.38 | 2019-2021 | |
| Exeltis, USA INC. | $103.82 | 2020-2025 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $89.67 | 2020-2023 | |
| Myovant Sciences INC. | $84.26 | 2022 | |
| Aspira Women'S Health INC | $80.36 | 2020-2021 | |
| Astellas Pharma US INC | $76.78 | 2021-2025 | Veozah |
| Pfizer INC. | $74.51 | 2019-2021 | |
| Coopersurgical, INC. | $64.49 | 2020-2025 | Paragard T 380a |
| Allergan, INC. | $56.88 | 2019-2020 | |
| Avion Pharmaceuticals | $50.80 | 2020-2023 | Balcoltra |
| Amag Pharmaceuticals, INC. | $49.91 | 2019-2020 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $49.05 | 2021 | |
| Sumitomo Pharma America, INC. | $45.84 | 2023-2025 | Myfembree |
| Intuitive Surgical, INC. | $40.00 | 2019 | |
| Zyla Life Sciences, INC. | $37.49 | 2020 | |
| Minerva Surgical, INC | $36.22 | 2019 | |
| Hologic Sales and Service, LLC | $32.47 | 2022-2023 | Aptima, Thinprep 2000 Processor |
| Ucb, INC. | $26.06 | 2024 | Briviact |
| Sage Therapeutics, LLC | $25.70 | 2025 | Zurzuvae |
| Vertical Pharmaceuticals, LLC | $19.19 | 2020 | |
| Merit Medical Systems INC | $18.70 | 2023 | Stabilit |
| Kaleo, INC. | $16.15 | 2023 | Auvi-Q |
| Agile Therapeutics, INC. | $14.87 | 2021 | |
| Dynavax Technologies Corporation | $14.57 | 2022 | |
| Boston Scientific Corporation | $13.02 | 2019 | |
| Mylan Pharmaceuticals INC. | $11.93 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Elsworth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.